Best Pharma Stocks Based on Predictive Analytics : Returns up to 28.01% in 14 Days

Pharma Stocks Forecast Package Name: Pharma Stocks
Recommended Positions: Long
Forecast Length: 14 Days (08/02/2018 - 08/16/2018)
I Know First Average: 4.22%

Read The Full Forecast

Best Pharma Stocks

Quick Win by the Algorithm: Luminex (NASDAQ: LMNX) New Treatments Drives Stock Price

“The rewards fro biotechnology are tremendous – to solve disease, eliminate poverty, age gracefully. It sounds so much cooler than Facebook.”

-George M. Church

(Source: Luminex)

Luminex Corporation (NASDAQ: LMNX) is a biotechnology company. The company develops, manufactures, and sells biological testing technology and products for the purpose of diagnostics, research, and pharmaceutical needs. Founded in 1995, the company currently has 896 employees.

On April 23rd, 2018, the I Know First Algorithm forecasted a bullish 3 months for LMNX. With

Read More

Best Pharma Stocks Based on Data Mining: Returns up to 32.13% in 1 Month

Pharma Stocks Forecast Package Name: Pharma Stocks
Recommended Positions: Long
Forecast Length: 1 Month (07/01/2018 - 08/01/2018)
I Know First Average: 9.08%

Read The Full Forecast

Best Pharma Stocks

Best Pharma Stocks Based on Deep Learning: Returns up to 4.50% in 14 Days

Pharma Stocks Forecast Package Name: Pharma Stocks
Recommended Positions: Long
Forecast Length: 14 Days (07/10/2018 - 07/24/2018)
I Know First Average: 2.16%

Read The Full Forecast

Best Pharma Stocks

Winning Stock Forecast: Celsion Corp. (NASDAQ: CLSN) Gained Nearly 30% Up Move For Promising Research Pipeline

Winning Stock Forecast

“Celsion continues to make significant progress with our two ongoing clinical development programs for ThermoDox® and GEN-1.  With sound fundamentals and a strong balance sheet, we are well positioned to complete enrollment in our ongoing 550 patient global, pivotal Phase III OPTIMA Study in primary liver cancer and to initiate our 130 patient Phase I/II randomized OVATION II Study in newly diagnosed patients with ovarian cancer in June 2018 and reporting clinical findings from the Phase I cohort of 12 patients of the OVATION II by the end of 2018.” -Michael H. Tardugno, chairman

Read More

Winning Stock Forecast: OPK Returns 30.46% in 7 Days, Fueled by Future Drug Expectations

“Scientific advancement should aim to affirm and to improve human life.”

– Nathan Deal

(Source: Cleveland Clinic)

OPKO Health, Inc. (NASDAQ: OPK) is a diversified healthcare company. Incorporated on November 18, 1991, the company’s segments include pharmaceutical, diagnostics, and corporate. The company’s pharmaceutical operations are in Chile, Mexico, Ireland, Israel, and Spain.

On July 5, I Know First Algorithm gave a bullish 7 day forecast for OPK. Since then, the stock has returned up to 30.46%.

Why did OPK see this sudden rise in

Read More

Best Pharma Stocks Based on Big Data Analytics : Returns up to 28.78% in 14 Days

Pharma Stocks Forecast Package Name: Pharma Stocks
Recommended Positions: Long
Forecast Length: 14 Days (07/04/2018 - 07/18/2018)
I Know First Average: 7.63%

Read The Full Forecast

Best Pharma Stocks
Pages:1234567...22»